Impromidine hydrochloride NEW
| Price | $258 | $642 | $913 |
| Package | 1mg | 5mg | 10mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2024-11-19 |
Product Details
| Product Name: Impromidine hydrochloride | CAS No.: 65573-02-6 |
| Purity: 99.50% | Supply Ability: 10g |
| Release date: 2024/11/19 |
Product Introduction
Bioactivity
| Name | Impromidine hydrochloride |
| Description | Impromidine hydrochloride is a very potent and specific histamine H2 receptor agonist for conducting cardiovascular studies. |
| In vitro | Impromidine hydrochloride (1 X 10(-4) M; human isolated left ventricular) inhibited maximal responses to histamine to a level equal to the maximal Impromidine hydrochloride response; however, Impromidine hydrochloride did not inhibit responses to isoprenaline. Positive inotropic activity and inhibition of maximal responses to histamine occurred over a similar Impromidine hydrochloride concentration range. Impromidine hydrochloride displaced histamine concentration-response curves to the right, whereas mepyramine had no effect on responses to histamine. It is concluded that Impromidine hydrochloride has positive inotropic activity on the human ventricle, that the response is mediated via histamine H2-receptors, and that Impromidine hydrochloride is a partial agonist compared with histamine.[2] |
| In vivo | Impromidine hydrochloride (0.46 to 46 nmol/kg/h; dog; 45-min steps) produced the same maximum stimulation of gastric HCI output, increase of HR, and fall in systolic blood pressure as histamine. Impromidine hydrochloride was 38 times more potent than histamine in the stimulation of acid (ED50 3.8 nmol/kg/h) and 30 times more potent in raising HR (ED50 5.6 vs. 172 nmol/kg.hr). The effects of Impromidine hydrochloride on pepsin secretion were qualitatively and quantitatively similar to those of histamine and other H-2 agonists with weak stimulation at low doses and progressive inhibition with increasing doses of Impromidine hydrochloride. Coupling the results with the known high specificity of Impromidine hydrochloride, gastric acid secretion, chronotropic, and hypotension all seem to be purely H-2-mediated effects of histamine in the intact conscious dog.[1] |
| Storage | store under nitrogen | Shipping with blue ice. |
| Solubility Information | DMSO : 27.5 mg/mL (63.83 mM), Sonication is recommended. |
| Keywords | Impromidine HCl | Impromidine trihydrochloride | Impromidine Hydrochloride |
| Inhibitors Related | Meclizine dihydrochloride | Mirtazapine | Lidocaine | Famotidine | Mebhydrolin napadisylate | Sodium butanoate | Amitriptyline hydrochloride | Alginic acid | Trazodone hydrochloride | Mianserin hydrochloride |
| Related Compound Libraries | Pain-Related Compound Library | Bioactive Compound Library | Neuronal Signaling Compound Library | Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | GPCR Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $2800.00/100mg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2024-10-28 | |
| $0.00/1kg |
VIP3Y
|
Wuhan Senwayer Century Chemical Co.,Ltd
|
2022-10-28 | |
| $50.00/1KG |
VIP2Y
|
Henan Fengda Chemical Co., Ltd
|
2023-12-22 |
United States- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY